ICD 10 CM D21.2 | Description & Clinical Information

ICD 10 D21.2 describes a specific medical condition characterized by the presence of an abnormal mass of cells that lacks the ability to invade surrounding tissues, affecting the connective and soft tissue of the lower extremity and/or hip, which includes muscles, fascia and synovia, tendons, ligaments, cartilage, stromal tissues, and blood and lymph vessels, and is identified as a type of benign neoplasm, other than lipoma, hemangioma, or lymphangioma, that is not represented by any other category or subcategory.

Official Description Of D21.2

The ICD 10 CM book defines ICD 10 code D21.2 as:

Benign neoplasm of connective and other soft tissue of lower limb, including hip
Parent Code Notes: D21

Includes: benign neoplasm of blood vessel
benign neoplasm of bursa
benign neoplasm of cartilage
benign neoplasm of fascia
benign neoplasm of fat
benign neoplasm of ligament, except uterine
benign neoplasm of lymphatic channel
benign neoplasm of muscle
benign neoplasm of synovia
benign neoplasm of tendon (sheath)
benign stromal tumors

Excludes1: benign neoplasm of articular cartilage (D16.-)
benign neoplasm of cartilage of larynx (D14.1)
benign neoplasm of cartilage of nose (D14.0)
benign neoplasm of connective tissue of breast (D24.-)
benign neoplasm of peripheral nerves and autonomic nervous system (D36.1-)
benign neoplasm of peritoneum (D20.1)
benign neoplasm of retroperitoneum (D20.0)
benign neoplasm of uterine ligament, any (D28.2)
benign neoplasm of vascular tissue (D18.-)
hemangioma (D18.0-)
lipomatous neoplasm (D17.-)
lymphangioma (D18.1)
uterine leiomyoma (D25.-)

When To Use D21.2

The diagnosis describes by the ICD 10 CM D21.2 code denotes a benign neoplasm of connective and soft tissues in the lower extremity and/or hip area. This condition often develops asymptomatically in the early stages of tumor growth. However, as the growth continues and the mass becomes bigger, the patient may experience visible and/or palpable lumps or swelling. These symptoms are typically painless, but they may cause pain, soreness, numbness, and restricted movement, making everyday activities such as sitting, standing, and walking difficult.

Diagnosis of this condition entails taking the patient’s history and conducting a physical examination. Laboratory tests such as cytogenetic analysis is also conducted, which involves testing a tissue sample under a microscope to determine whether or not any chromosomal abnormalities exist. In many cases, a biopsy of the mass is necessary to confirm diagnosis. A biopsy is performed by fine needle aspiration or open biopsy if the lump is palpable.

Imaging tests like X-rays, CT scans, MRI or PET scans can also be done to provide detailed images of the affected area. These tests help in diagnosing the condition and in deciding on the most effective course of treatment. In some cases, a combination of diagnostic tests is used to determine the best method of treating the benign neoplasm.

The preferred option for treating the condition is surgery, which involves the removal of the abnormal mass. The surgical approach taken will depend on the size, the location and the complexity of the mass. Other supportive methods may be recommended to relieve any symptoms the patient is experiencing. For example, physical therapy may be prescribed to help regain mobility and strength in the affected area.

It is important for patients to seek medical attention whenever they notice any abnormal lumps, bumps or swelling in the lower extremities or hip region. Early detection and treatment of benign neoplasms can lessen the morbidity rate and improve the prognosis. Furthermore, as a medical coder, it is important to understand the details surrounding the diagnosis code D21.2 so that accurate coding can be performed for insurance purposes and proper reimbursement can be ensured for the medical facility.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *